Article Information
History
- December 17, 2018.
Article Versions
- Version 1 (January 22, 2018 - 09:20).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Correspondence to:
Dr Tim Ellison Address: PharmaGenesis London, 9 Whitehall, 4th Floor, London, SW1A 2DD Email: tim.ellison{at}pharmagenesis.com Phone: +44 203 675 7065